- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05470686
Study of the Relationship Between the Oxygenation State and Lung Ultrasound Score in Cardiac Surgery (PaFiKinESAP)
Study of the Relationship Between the Relative Variation of PaO2/FiO2 and the Variation of Lung Ultrasound Score During the First Session of Physiotherapy Associated With Non-invasive Ventilation in Cardiac Surgery Patients by Cardiopulmonary Bypass
After conventional cardiac surgery, many respiratory complications are possible. Therefore, the resuscitator prescribe physiotherapy and non invasive ventilation. The physiotherapist has few reliable tools to evaluate and follow the patient on his ventilatory function. Currently, lung ultrasound is little used in physiotherapy and no study explains the link between the lung ultrasound results and oxygenation patient state. Before considering the interest of lung ultrasound score as a criterion of effectiveness of a physiotherapy treatment through future studies, it is first important to objectivize the existence of a relationship between lung ultrasound score and the PaO2/FiO2 ratio after cardiac surgery. Lung ultrasound could provide direct clinical information without having to resort to other more invasive examinations to objectify the improvement of the patient's oxygenation.
Main objective To show that the relative change in the PaO2/FiO2 ratio correlates with the change in lung ultrasound score measured in the short term between the beginning and the end of the first physiotherapy session associated with non invasive ventilation the day after surgery in cardiac patients
Secondary objectives
- To study the inter-operator (2 readers) reproducibility of the lung ultrasound score measurement.
- To study the relationship between the relative variation of the PaO2/FiO2 ratio and the variation of each of the 12 zones of the lung ultrasound score
- To Study the relationship between the initial lung ultrasound score and the relative variation of the PaO2/FiO2 ratio
- To study the relative variation of the PaCO2 and the variation of the lung ultrasound score between the beginning and the end of the first session of physiotherapy management associated with NIV
- To obtain from the patient in the short term feedback on his or her understanding of the explanations about lung ultrasound score provided by the physiotherapist during the session
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Aurelie ROTH OUDIN
- Phone Number: 03 83 15 41 96
- Email: a.roth@chru-nancy.fr
Study Locations
-
-
-
Vandœuvre-lès-Nancy, France, 54511
- Recruiting
- CentralHNF
-
Contact:
- Aurelie ROTH OUDIN
- Phone Number: 03 83 15 41 96
- Email: a.roth@chru-nancy.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Person having received complete information on the organization of the research and having given written consent to participate
- Person having benefited from a heart surgery under cardio-pulmonary bypass
- Medical prescriptions for non invasive ventilation and physiotherapist
- Age ≥ 18 years
- 18.5 ≤ BMI ≤ 35 kg/m2
- Visual Analogy Scale pain < 4
- Patient conscious and oriented: Glasgow 15/15
Exclusion Criteria:
- At the patient's request : a patient may withdraw from the research at any time without affecting the quality of care to which he or she is entitled (withdrawal of consent).
- Cardiorespiratory arrest during the inclusion visit.
- Need for orotracheal reintubation during the inclusion visit.
- Patient non-cooperation during the inclusion visit.
- Failure of the ultrasound machine during the inclusion visit.
- Failure of the blood gas analyzer.
- Glasgow < 15 during the inclusion visit
- PEEP > 6 cmH2O required during physiotherapy + non invasive ventilation session
- PEEP < 6 cmH2O required during physiotherapy + non invasive ventilation session
- Premature interruption of the physiotherapy session + non invasive ventilation not hemodynamically tolerated
- Need for a session of non invasive ventilation + physiotherapy > 30 minutes.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: HEART SURGERY PATIENTS with cardio pulmonary bypass
|
Patients will have a blood sample plus a lung ultrasound before and after the physical therapy session combined with non invasive ventilation the morning after the heart surgery
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in lung ultrasound score: measurement after - measurement before the physiotherapy session + non invasive ventilation
Time Frame: the morning after the heart surgery
|
Lung ultrasound score = global measurement on 12 thoracic regions (6 per hemithorax: 2 anteriors, 2 laterals, 2 posteriors) to obtain a result out of 36 (sum of all values found in each zone). Each zone is evaluated as follows: 0 = normal ventilation
|
the morning after the heart surgery
|
|
Relative difference in PaO2/FiO2 ratio: (measurement after - measurement before the physiotherapy session + non invasive ventilation) / measurement before.)
Time Frame: the morning after the heart surgery
|
The higher the ratio, better is the result.
Between approximately 0 and 400
|
the morning after the heart surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
For each subject, answers to two questions at the end of the session about his or her understanding of PAS after the information provided by the MK during the session
Time Frame: the morning after the heart surgery
|
Questions asked by the physiotherapist for the patient (at the end of the session) :
Translated with www.DeepL.com/Translator (free version) |
the morning after the heart surgery
|
|
Lung ultrasound score values obtained by both evaluators from the same recorded ultrasound images. If there is a difference of one point between the two scores measured, a third reading by a doctor will be taken. This 3rd score will then be retained.
Time Frame: in the week following the measurements
|
If there is a difference of one point between the two scores measured, a third reading by a doctor will be taken.
This 3rd score will then be retained.
|
in the week following the measurements
|
|
relative difference in PaO2/FiO2 ratio
Time Frame: the morning after the heart surgery
|
The higher the ratio, better is the result.
Between approximately 0 and 400
|
the morning after the heart surgery
|
|
difference in lung ultrasound score for each study area
Time Frame: the morning after the heart surgery
|
Each zone is rated from 0 to 3 points.
The lower the score, the better the result.
We look to see if the score for each zone decreases between before and after the physiotherapy session.
|
the morning after the heart surgery
|
|
initial lung ultrasound score
Time Frame: the morning after the heart surgery
|
Lung ultrasound score = global measurement on 12 thoracic regions (6 per hemithorax: 2 anteriors, 2 laterals, 2 posteriors) to obtain a result out of 36 (sum of all values found in each zone). Each zone is evaluated as follows: 0 = normal ventilation
|
the morning after the heart surgery
|
|
relative difference in PaCO2
Time Frame: the morning after the heart surgery and after physiotherapy session
|
The lower the score, the better the result.
Ap proximately between 0 and 100
|
the morning after the heart surgery and after physiotherapy session
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Jean PAYSANT, Central Hospital, Nancy, France
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2022-A01478-35
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Surgery
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Sheba Medical CenterTerminatedDisorder; Heart, Functional, Postoperative, Cardiac Surgery | Heart; Dysfunction Postoperative, Cardiac SurgeryIsrael
-
Kocaeli Derince Education and Research HospitalKocaeli UniversityUnknownEnhanced Recovery After Surgery | Open Heart SurgeryTurkey
-
Centre Hospitalier Universitaire DijonCompleted
-
Shahid Beheshti UniversityKerman University of Medical SciencesCompletedHeart SurgeryIran, Islamic Republic of
-
Eurosets S.r.l.RecruitingCardiac Surgery | Cardiopulmonary Bypass | Heart Surgery | Aortic Valve Surgery | Cannulation | Coronary Surgery With Cardiopulmonary Bypass | Coronary Surgery | Arterial Cannulation | Venous CannulationItaly
-
Centre Hospitalier Universitaire, AmiensCompleted
-
Catharina Ziekenhuis EindhovenCompleted
-
University Hospital Plymouth NHS TrustCompleted
-
Shaare Zedek Medical CenterUnknownPatients Undergoing Open Heart Surgery | Patients Undergoing Lung SurgeryIsrael
Clinical Trials on blood gas via arterial catheter
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Akdeniz UniversityCompletedHyperoxia | Kidney Transplant; Complications | Graft DysfunctionTurkey
-
Ismail Erkan AydinCompleted
-
Vincenzo CannizzaroActive, not recruitingInfant, Newborn, Diseases | Critical Illness | Lung Diseases, Obstructive | Lung Diseases, Interstitial | Heart Defects, Congenital | Child, Only | ARDS, HumanSwitzerland
-
Brigham and Women's HospitalChinese PLA General Hospital; Guangdong Provincial People's Hospital; Guangzhou...Completed
-
University Hospital, AngersUnknownAcute Respiratory Distress SyndromeFrance
-
Memorial Health University Medical CenterUnknownRespiratory ComplicationUnited States
-
Prince of Songkla UniversityCompletedCongenital Heart Disease | Perioperative/Postoperative Complications | Lactate Blood IncreaseThailand
-
Università degli Studi di FerraraUniversity of MilanNot yet recruitingEmergencies | Acute Respiratory Failure | Ventilation Therapy; Complications | Abdominal SepsisItaly
-
Meir Medical CenterNot yet recruiting